Related to that, in glioblastoma, BCP was reported to work as a tumor suppressor, regulating the CB2 receptor that activates PPARg and inhibits NF-κB and TNF-a, and subsequently reduces Jun N-Terminal Kinase (JNK) expression [19]. This evidence concerns the gene TNF and neoplasm.